ProterixBio, Inc. will present results from multiple clinical studies at the American Thoracic Society International Conference, to be held May 18-23, 2018 at the San Diego Convention Center, San Diego, CA. The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

ProterixBio will be presenting three posters that highlight new results for the company’s advanced molecular assessments to improve the care of COPD patients:

“Prospective Evaluation of Algorithms Based on Blood Biomarkers as Guides for COPD Assessment and Risk Stratification,” Poster Board Number: P1367, Viewing Time: 11:15-1:00 on Monday, May 21^st.

“Blood Biomarker Algorithms as an Aide to Describe Exacerbations Activity in Symptomatic Smokers and Early Staged COPD Patients,” Poster Board Number: 601, Viewing Time: 9:15-9:45, Discussion Time: 9:45-11:15 on Monday, May 21^st.

“Forest Algorithms Based Upon Blood Biomarkers as an Aide in Phenotyping the COPD Frequent Severe Exacerbator,” Poster Board Number: 602, Viewing Time: 9:15-9:45, Discussion Time: 9:45-11:15 on Monday, May 21^st.

For more information, see:

http://conference.thoracic.org/